Search - tctmd.com

Displaying 441 - 460 of 1337

Sort: Relevancy | Date

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2017

Amit K. Gupta, MBBS, MD

October 26, 2017

News Daily News

Female Surgeons Hold Slight Edge Over Male Peers in Terms of Patients’ 30-Day Mortality

Caitlin E. Cox

October 11, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

Presentation CDM 2017

Femoral CTO: A Stepwise Approach for Recanalization

Presenter: Lawrence A. Garcia

October 05, 2017

Presentation CDM 2017

Transitiong From a CAD to Peripheral Vascular Disease Practice

Presenter: Terry R. Bowers

October 05, 2017

Presentation VIVA 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presenter: Ehrin J. Armstrong

September 19, 2017

News Industry News

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

September 19, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

Presentation VIVA 2017

Results from the IN.PACT SFA Randomized Trial

Presenter: Peter A. Schneider

September 15, 2017

Presentation VIVA 2017

Two-year Results from the IN.PACT Global Study

Presenter: Thomas Zeller

September 14, 2017

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Conference News VIVA 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

L.A. McKeown

September 11, 2017

Podcast TCTMD Talking Points

Episode 29: ILLUMENATE US: A Paclitaxel-Coated Balloon vs an Uncoated Balloon for Diseased Superficial Femoral and Popliteal Arteries

September 06, 2017

Presentation iASSESS 2017

Femoral Access and Related Complications

Presenter: Arnold Seto

August 30, 2017

Presentation CHIP Seattle 2017

Device Therapy for Cardiogenic Shock

Presenter: Jennifer A Tremmel

August 11, 2017

Presentation CHIP Seattle 2017

Complications: Managing Access Site Complications

Presenter: Colm Hanratty

August 11, 2017

News Daily News

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Michael O'Riordan

August 09, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

Advertisement

My Picks for Fellows Attending TCT 2017

Female Surgeons Hold Slight Edge Over Male Peers in Terms of Patients’ 30-Day Mortality

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Femoral CTO: A Stepwise Approach for Recanalization

Transitiong From a CAD to Peripheral Vascular Disease Practice

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

Results from the IN.PACT SFA Randomized Trial

Two-year Results from the IN.PACT Global Study

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

Episode 29: ILLUMENATE US: A Paclitaxel-Coated Balloon vs an Uncoated Balloon for Diseased Superficial Femoral and Popliteal Arteries

Femoral Access and Related Complications

Device Therapy for Cardiogenic Shock

Complications: Managing Access Site Complications

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content